Literature DB >> 25173795

Predictors of presenteeism and activity impairment outside work in patients with spondyloarthritis.

Emma Haglund1, Ingemar F Petersson, Ann Bremander, Stefan Bergman.   

Abstract

PURPOSES: To assess predictors of presenteeism (reduced productivity at work) and activity impairment outside work in patients with spondyloarthritis (SpA).
METHODS: Multivariate logistic regression analysis was used to study predictors of presenteeism and activity impairment in 1,253 patients with SpA based on a 2.5 year follow-up questionnaire. The Work Productivity and Activity Impairment (WPAI) questionnaire was used as main outcome. Age, gender, lifestyle factors, subgroups, disease duration, and different patient reported outcome measures (PROMs) were studied as possible predictors. The association between presenteeism and WPAI activity impairment outside work was assessed.
RESULTS: Out of 1,253 patients, 757 reported being in work and of these 720 responded to the WPAI questionnaire. The mean (confidence interval, CI) reported presenteeism was 25% (23-27%) and mean activity impairment 33% (31-35%) (0-100%, 0 = no reduction). Significant predictors of presenteeism and activity impairment at follow-up (controlled for gender, age, spondyloarthritis subgroups and presenteeism at baseline) were presenteeism at baseline, poor quality of life, worse disease activity, decreased physical function, lower self-efficacy pain and symptom, higher scores of anxiety, depression, smoking and low education level, and for activity impairment also female sex. There was a strong association between presenteeism and activity impairment outside work (OR 16.7; 95% CI 11.6-24.3; p < 0.001).
CONCLUSIONS: Presenteeism and activity impairment were not only predicted by presenteeism at baseline, but also by several PROMs commonly used in clinical rheumatology practice. Impaired activity outside work could indicate problems also at work suggesting why both areas need to be addressed in the clinical situation.

Entities:  

Mesh:

Year:  2015        PMID: 25173795     DOI: 10.1007/s10926-014-9537-2

Source DB:  PubMed          Journal:  J Occup Rehabil        ISSN: 1053-0487


  40 in total

1.  Healthcare costs and productivity losses directly attributable to ankylosing spondylitis.

Authors:  Rachid Rafia; Roberta Ara; Jon Packham; Kristie L Haywood; Emma Healey
Journal:  Clin Exp Rheumatol       Date:  2012-04-13       Impact factor: 4.473

2.  The validity and reproducibility of a work productivity and activity impairment instrument.

Authors:  M C Reilly; A S Zbrozek; E M Dukes
Journal:  Pharmacoeconomics       Date:  1993-11       Impact factor: 4.981

3.  Impact of ankylosing spondylitis on work in patients across the UK.

Authors:  E L Healey; K L Haywood; K P Jordan; A Garratt; J C Packham
Journal:  Scand J Rheumatol       Date:  2010-08-20       Impact factor: 3.641

4.  Prevalence of spondyloarthropathies in France: 2001.

Authors:  A Saraux; F Guillemin; P Guggenbuhl; C H Roux; P Fardellone; E Le Bihan; A Cantagrel; I Chary-Valckenaere; L Euller-Ziegler; R-M Flipo; R Juvin; J-M Behier; B Fautrel; C Masson; J Coste
Journal:  Ann Rheum Dis       Date:  2005-04-07       Impact factor: 19.103

5.  Which aspects of functioning are relevant for patients with ankylosing spondylitis: results of focus group interviews.

Authors:  Annelies Boonen; Monique van Berkel; Alarcos Cieza; Gerold Stucki; Désirée van der Heijde
Journal:  J Rheumatol       Date:  2009-10-15       Impact factor: 4.666

6.  Identification of the most common problems by patients with ankylosing spondylitis using the international classification of functioning, disability and health.

Authors:  Irene van Echteld; Alarcos Cieza; Annelies Boonen; Gerold Stucki; Jane Zochling; Jürgen Braun; Désirée van der Heijde
Journal:  J Rheumatol       Date:  2006-10-15       Impact factor: 4.666

7.  Musculoskeletal pain in the workforce: the effects of back, arthritis, and fibromyalgia pain on quality of life and work productivity.

Authors:  Margaret McDonald; Marco daCosta DiBonaventura; Stacey Ullman
Journal:  J Occup Environ Med       Date:  2011-07       Impact factor: 2.162

8.  Worker productivity loss associated with arthritis.

Authors:  Wayne N Burton; Chin-Yu Chen; Alyssa B Schultz; Daniel J Conti; Glenn Pransky; Dee W Edington
Journal:  Dis Manag       Date:  2006-06

9.  Impact of age, sex, physical function, health-related quality of life, and treatment with adalimumab on work status and work productivity of patients with ankylosing spondylitis.

Authors:  Walter P Maksymowych; Katherine L Gooch; Robert L Wong; Hartmut Kupper; Désirée van der Heijde
Journal:  J Rheumatol       Date:  2009-12-01       Impact factor: 4.666

10.  A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index.

Authors:  A Calin; S Garrett; H Whitelock; L G Kennedy; J O'Hea; P Mallorie; T Jenkinson
Journal:  J Rheumatol       Date:  1994-12       Impact factor: 4.666

View more
  9 in total

Review 1.  Nocturia Work Productivity and Activity Impairment Compared with Other Common Chronic Diseases.

Authors:  Paul S J Miller; Harry Hill; Fredrik L Andersson
Journal:  Pharmacoeconomics       Date:  2016-12       Impact factor: 4.981

2.  Persistence of tumor necrosis factor inhibitor or conventional synthetic disease-modifying antirheumatic drug monotherapy or combination therapy in psoriatic arthritis in a real-world setting.

Authors:  Philip J Mease; Neil A Accortt; Sabrina Rebello; Carol J Etzel; Ryan W Harrison; Girish A Aras; Mahdi M F Gharaibeh; Jeffrey D Greenberg; David H Collier
Journal:  Rheumatol Int       Date:  2019-07-18       Impact factor: 2.631

3.  Work productivity is associated with disease activity and functional ability in Italian patients with early axial spondyloarthritis: an observational study from the SPACE cohort.

Authors:  Manouk de Hooge; Roberta Ramonda; Mariagrazia Lorenzin; Paola Frallonardo; Leonardo Punzi; Augusta Ortolan; Andrea Doria
Journal:  Arthritis Res Ther       Date:  2016-11-16       Impact factor: 5.156

4.  Axial Spondyloarthritis and Cigarette Smoking.

Authors:  Irène Kona Kaut; Fatima Ezzhara Abourazzak; Essouri Jamila; Florine Awassi Sènami; Desiré Diketa; Harzy Taoufik
Journal:  Open Rheumatol J       Date:  2017-05-31

5.  Improvements in workplace and household productivity with certolizumab pegol treatment in axial spondyloarthritis: results to week 96 of a phase III study.

Authors:  Désirée van der Heijde; Jürgen Braun; Martin Rudwaleit; Oana Purcaru; Arthur F Kavanaugh
Journal:  RMD Open       Date:  2018-04-09

6.  Methodological aspects of design, analysis and reporting of studies with work participation as an outcome domain in patients with inflammatory arthritis: results of two systematic literature reviews informing EULAR points to consider.

Authors:  Mary Lucy Marques; Alessia Alunno; Sofia Ramiro; Polina Putrik; Annelies Boonen; Marieke M Ter Wee; Louise Falzon
Journal:  RMD Open       Date:  2021-02

7.  Patient-Reported Impact of Axial Spondyloarthritis on Working Life: Results From the European Map of Axial Spondyloarthritis Survey.

Authors:  Marco Garrido-Cumbrera; Christine Bundy; Victoria Navarro-Compán; Souzi Makri; Sergio Sanz-Gómez; Laura Christen; Raj Mahapatra; Carlos J Delgado-Domínguez; Denis Poddubnyy
Journal:  Arthritis Care Res (Hoboken)       Date:  2021-12       Impact factor: 5.178

8.  Presenteeism in a Dutch hand eczema population-a cross-sectional survey.

Authors:  Jart A F Oosterhaven; Peter A Flach; Ute Bültmann; Marie L A Schuttelaar
Journal:  Contact Dermatitis       Date:  2018-04-01       Impact factor: 6.600

9.  Sick leave in early axial spondyloarthritis: the role of clinical and socioeconomic factors. Five-year data from the DESIR cohort.

Authors:  Elena Nikiphorou; Pedro D Carvalho; Annelies Boonen; Bruno Fautrel; Pascal Richette; Pedro M Machado; Desirée van der Heijde; Robert Landewé; Sofia Ramiro
Journal:  RMD Open       Date:  2021-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.